Related Experiment Video
Updated: Aug 29, 2026

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
Cyclooxygenase-2 expression and its relationship with proliferation of colorectal adenomas
Takanobu Sato1, Keigo Yoshinaga, Satoshi Okabe
1Digestive Surgery, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. sato@po.kyoundo.jp
Background:
Cyclooxygenase (COX)-2 may be linked to carcinogenesis. In the previous study, we examined COX-2 expression immunohistochemically in 95 adenomas and reported a significant correlation between its expression and the grade of dysplasia. To clarify the correlation between COX-2 expression and cell proliferation, we investigated Ki-67 labeling index using immunohistochemistry and its correlation with COX-2 expression.
Methods:
Immunohistological staining for Ki-67 antigen was performed on 95 colorectal adenomas previously reported.
Results:
The Ki-67 labeling index was significantly higher in the high-COX-2 group than in the low-COX-2 and negative groups in adenomas with moderate (44.5 +/- 6.4% vs 33.0 +/- 2.6%, 39.0 +/- 6.2%; P = 0.01, P < 0.001, respectively) or severe dysplasia (47.2 +/- 7.6% vs 40.3 +/- 7.2%, 35.0 +/- 5.4%; P = 0.02, P = 0.005, respectively). There was no correlation between Ki-67 labeling index and COX-2 expression in mild dysplasia.
Conclusions:
These results suggest that COX-2 may play a causal role in cell proliferation in carcinogenesis.
Related Concept Videos
Abnormal Proliferation
Inflammatory Bowel Disease II: Ulcerative Colitis
Positive Regulator Molecules
Inhibition of Cdk Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

